knowledge -WSS

knowledge

author：comprehensive 2025-09-05 11:30:06 - browse：886

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

hotspot

WSS

Extreme heat events are a public health emergency

What is STAT's opinion section for?

A letter from the executive editor: STAT UnitedHealth investigation

HPV cancer vaccine study demonstrates efficacy

More doctors should go into startup world

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

knowledge

knowledge

Wikipedia

Activists slam private health insurers over coverage restrictions

10 million people disenrolled from Medicaid over past six months

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA reorg will put new emphasis on investigations, sources say

Novavax promises a turnaround & Lilly roils the obesity market

Biotech incubator Curie.Bio graduates its first startup

Medical leaders decry Supreme Court decision on affirmative action

Weight loss drugs should be covered by insurers, AMA says

Walensky prepares to leave CDC — and Congress — behind

Victims of gun violence feel impacts long after bullet wound

entertainment

Carbon Health diabetes program, a test of data

What health policies could hitch a ride on a spending bill?

Medicare’s new pay boost for primary care is angering specialists

After decades in use, heart stents finally beat placebo

Removing probiotics from the NICU could threaten preemies' health

Just how powerful is the placebo effect?

hotspot

hotspot

focus

focus